3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

Chemicals in curry, onions may shrink colon polyps

CancerAug 03, 06

Compounds found in curry and onions may help prevent colon cancer in those at risk, according to findings from a small study released this week.

In the study, patients with pre-cancerous polyps in the colon who took a pill containing a combination of curcumin, which is found in the curry spice turmeric, and quercetin, an antioxidant found in onions, experienced a marked reduction in both the size and number of polyps.

“We believe this is the first proof of principle that these substances have significant effects in patients with FAP (familial adenomatous polyposis),” Dr. Francis M. Giardiello of The Johns Hopkins School of Medicine in Baltimore said in a statement.

FAP is an inherited disorder characterized by the development of colorectal polyps and eventually colon cancer.

The potential of curcumin to prevent and/or treat cancer in the lower intestines surfaced in studies in lab rats fed curry, as well as in observational studies of Asian populations that consume a lot of curry. Quercetin has also been shown to have anti-cancer potential.

In their study, Giardiello and colleagues gave five FAP patients who had five or more polyps in their lower intestinal tract with 480 milligrams of curcumin and 20 milligrams of quercetin three times daily.

“All five patients had a decreased polyp number and size from baseline after a mean of 6 months,” the team reports in the medical journal Clinical Gastroenterology and Hepatology.

The average number of polyps dropped by 60 percent, and the average size dropped by 51 percent.

Side effects were minimal. One patient experienced nausea and sour taste within a couple of hours of taking the pill, which subsided after three days and did not recur, and another patient reported mild diarrhea.

Of the two compounds, the researchers believe curcumin is the key cancer-fighting agent. “The amount of quercetin we administered was similar to what many people consume daily; however, the amount of curcumin is many times what a person might ingest in a typical diet,” Giardiello explained.

The team says larger trials, comparing curcumin-quercetin capsules with dummy “placebo” pills, are needed to confirm these findings.

SOURCE: Clinical Gastroenterology and Hepatology, August 2006.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site